An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
Clinical trial NCT06534892 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06534892
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-09-30
- Enrollment
- 10212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.